Portfolio Transactions (March 2021)

Updates for my Portfolio for March 2021

Been really busy. Wanted to write an update but going home really tired and stuff is making it hard. Although my work bonus is a 6 year low, the increment made up for it by being the 6 year high. I do prioritise recurring cashflow as it is less variable and more predictable compared to a one of lump sum. Also, this increment has finally pushed my total monthly package (basic pay and allowances) to get the maximum CPF employer contribution. Hope my MA can be maxed out soon so that the SA can snowball faster.

 

I am still testing more ideas for a side project I am working on. I will test a larger batch to see how it goes, and just before it happened, found something to test again meh, probably the last one I am gonna test, else I will never get moving.

• Sell Silverlake Axis at 0.245 (Loss)
  
• Reasons 
• I finally throw in the towel.
• Management has made a decision to conserve the cash instead of paying out to shareholders with no explanation. What's more, to wait for SAL to grow again would be the next cycle.
• Figured I just sell and switch instead of waiting.
  

• Buy Adobe at 430
  
• Reasons
• Adding more to my position since it fell about 10% from my first tranche.
  

• Buy Facebook at 259.1798
  
• Reasons
• Nibbled a position as it was trading at a decent valuation at ~26x PE during a recent market dip.
• Although the recent privacy changes (such as from Apple), Facebook is still monopolistic in its industry and still growing. The ad efficiency would still need to be monitored though.
  
• 
  
   

• Buy Veeva Systems at 256
  
• Reasons
• Bought at about 108x PE (pricey, I know).
  
• Veeva Systems is a cloud-computing software-as-a-service for the life science industry with applications such as data management, regulatory compliance tools, and customer relationship management (yes, in spite of companies like Salesforce). Their customers range from large pharmaceuticals to emerging biotech firms. 
• Veeva provides a good way to access the healthcare and biopharma industry as a proxy. Digital transformation resulting from the Covid-19 pandemic actually would boost Veeva pipeline even further.
  
• 

 

That's all for my money for now. I stopped trading with VT because of funds being needed to route for share purchases.

The US market are slight red but still expensive, there's a counter that's almost reaching my initiation price. Hopefully, I can get other counters too.

Conclusion

My portfolio YTD is now ~24%, with the long term XIRR at 4.18%. Seems improving I hope.

My cash position is currently at about 15%. Probably keep an eye out for opportunities while conserving cash (there's still a balance transfer the size of about 10% of my portfolio ready).

Related Posts:

• Portfolio Transactions Update (February 2021)
  
• Portfolio Transactions Update (January 2021)
  
• Portfolio Transactions Update (December 2020)
  
• Portfolio Transactions Update (November 2020)
  
• Portfolio Transactions Update (October 2020)
  
• Portfolio Transactions Update (September 2020)